| Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy (NCT05154474) | Weprom | 2022-06-01 |
| A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) (NCT04988555) | Sumitomo Pharma America, Inc. | 2022-02-28 |
| CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL） (NCT03544021) | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | 2018-03-01 |
| DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL) (NCT03110354) | Daiichi Sankyo | 2017-04-05 |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors (NCT01100658) | University of Minnesota | 2010-05-01 |
| Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247) (NCT00907517) | Merck Sharp & Dohme LLC | 2009-07-29 |
| Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit (NCT01050946) | Medical College of Wisconsin | 2009-07-01 |
| Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage (NCT00905034) | M.D. Anderson Cancer Center | 2009-03-01 |
| NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic Leukemia (NCT00548431) | Rigshospitalet, Denmark | 2007-12-01 |
| Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan (NCT00526084) | National Taiwan University Hospital | 2007-03-01 |
| Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) (NCT00406393) | Medical College of Wisconsin | 2006-11-01 |
| Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor (NCT00393380) | The Emmes Company, LLC | 2006-09-01 |
| Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia (NCT00313053) | Clare Twist | 2004-09-01 |
| Post Transplant Donor Lymphocyte Infusion (NCT00167180) | Masonic Cancer Center, University of Minnesota | 2004-01-01 |
| Randomized Double Cord Blood Transplant Study (NCT00067002) | M.D. Anderson Cancer Center | 2003-04-01 |
| T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis (NCT01078337) | Stanford University | 2002-11-01 |
| Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML) (NCT00185523) | Stanford University | 2002-05-01 |
| Stem Cell Transplant for Hematological Malignancy (NCT00176930) | Masonic Cancer Center, University of Minnesota | 2001-10-01 |
| Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies (NCT00038883) | M.D. Anderson Cancer Center | 2001-04-09 |
| Adult ALL Treatment at Diagnosis (NCT00537550) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2000-07-01 |
| Stem Cell Transplantation for Hematological Malignancies (NCT00176839) | Masonic Cancer Center, University of Minnesota | 2000-06-07 |
| Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia (NCT00005892) | Fairview University Medical Center | 2000-03-01 |
| Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia (NCT00167167) | Masonic Cancer Center, University of Minnesota | 1995-12-01 |
| Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III (NCT00483132) | French Innovative Leukemia Organisation | 1994-09-01 |